JAK2 V617F mouse genotyping detection is an essential molecular testing service for laboratories that breed or study Jak2 V617F knock-in and transgenic mouse models of myeloproliferative neoplasms. By identifying the c.1849G>T point mutation in exon 14 of the murine Jak2 gene, researchers can accurately determine genotype, manage breeding colonies, and ensure experimental reproducibility. This article summarizes the technical principles, sample requirements, testing methods, and applications of JAK2 V617F mouse genotyping.
Technical Overview
The Janus kinase 2 (Jak2) gene encodes a non-receptor tyrosine kinase that plays a central role in the JAK-STAT signaling pathway downstream of hematopoietic cytokine receptors, including the erythropoietin receptor, the thrombopoietin receptor, and the granulocyte colony-stimulating factor receptor. The V617F mutation is a single guanine-to-thymine substitution (c.1849G>T) in exon 14 that replaces valine with phenylalanine at codon 617 within the pseudokinase (JH2) regulatory domain. This substitution disrupts the auto-inhibitory interaction between the JH2 and JH1 kinase domains, producing constitutive kinase activation, cytokine hypersensitivity, and uncontrolled proliferation of myeloid lineage cells.
In humans, JAK2 V617F is the hallmark driver mutation of Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), occurring in more than 95 percent of polycythemia vera cases and roughly half of essential thrombocythemia and primary myelofibrosis cases. Genetically engineered mice carrying the Jak2 V617F mutation, either knocked into the endogenous murine Jak2 locus or introduced as a mutant human transgene, develop splenomegaly, elevated hematocrit, leukocytosis, and progressive bone marrow fibrosis, faithfully recapitulating key features of human disease. Reliable genotyping of these animals is therefore indispensable for colony management, experimental cohort assignment, and reproducible disease modeling.
Because many published models rely on conditional strategies, such as lox-stop-lox cassettes activated by Cre recombinase under hematopoietic promoters, a complete genotyping workflow may require multiple primer sets that target the mutant allele, the floxed cassette, and the Cre transgene in parallel. Well-designed assays must also account for strain-specific single nucleotide polymorphisms in the genomic region surrounding codon 617, which can otherwise compromise primer binding and produce false results.
Testing Samples
Tail Tip and Ear Punch Biopsies
Tail tips of 2 to 5 millimeters collected at weaning, together with ear punches obtained during routine identification, are the standard samples for mouse genotyping. Genomic DNA is extracted by proteinase K digestion or silica-column purification, typically yielding sufficient template for dozens of PCR reactions. Samples may be shipped fresh on ice, stored frozen at minus 20 degrees Celsius or below, or preserved in 70 to 95 percent molecular biology grade ethanol for convenient ambient transport.
Blood and Buccal Swab Samples
Small volumes of peripheral blood collected from the tail vein or submandibular vein are acceptable, preferably in EDTA anticoagulant tubes because heparin strongly inhibits PCR. Blood spotted and dried on FTA cards is also suitable and greatly simplifies long-distance shipping. Buccal swabs offer a non-invasive alternative, although DNA yield is lower and repeat sampling is occasionally required for young pups.
Other Tissue and Archived Samples
Spleen, bone marrow, liver, and archived frozen tissue can be analyzed when retrospective genotyping is needed or when verification of transplant donor origin is required. For disease-monitoring studies, genotyping of hematopoietic tissues can be combined with allele-burden measurement to track clonal expansion over time. Formalin-fixed paraffin-embedded material can also be processed using short amplicon designs, although DNA quality should be assessed with an internal control.
Testing Items
A comprehensive JAK2 V617F genotyping panel covers all genotype classes and model configurations commonly used in MPN research. Standard reporting items include:
- Wild-type confirmation (Jak2+/+) for baseline breeders and control cohorts.
- Heterozygous mutant identification (Jak2 V617F/+) for the majority of experimental MPN models.
- Homozygous mutant identification (Jak2 V617F/V617F), where the specific model supports viability.
- Transgene screening for strains carrying mutant human JAK2V617F constructs.
- Conditional element verification, including lox-stop-lox cassettes and Cre recombinase genotyping.
- Allele burden quantification, expressed as the mutant-to-wild-type allele ratio, for mosaic or transplantation studies.
Testing Methods
Allele-Specific PCR (AS-PCR)
Three-primer allele-specific PCR is the workhorse method for routine colony genotyping. A common reverse primer is combined with a wild-type-specific forward primer and a mutant-specific forward primer, each carrying a deliberate mismatch near the 3' end to maximize discrimination between the two alleles. Wild-type animals produce a single wild-type band, homozygous mutants produce a single mutant band, and heterozygotes produce both bands on agarose gel electrophoresis. An internal control amplicon is co-amplified to confirm DNA integrity and to rule out false homozygous calls caused by reaction failure.
PCR-RFLP Analysis
The c.1849G>T substitution alters a BsaXI recognition site within exon 14, allowing PCR products to be distinguished by restriction digestion. Wild-type amplicons are cleaved into defined fragments, whereas mutant amplicons remain uncut or produce a distinct fragment pattern. This approach provides an economical orthogonal confirmation when primer-specific PCR results are ambiguous, and digested products are visualized directly on high-resolution agarose gels.
Sanger Sequencing
Bidirectional Sanger sequencing of exon 14 amplicons serves as the confirmatory gold standard. Sequencing directly verifies the G to T substitution at position c.1849, determines zygosity from the relative height of overlapping peaks, and can reveal additional variants or strain-background polymorphisms that complicate primer binding. Chromatograms are archived with the final report to support full traceability.
Quantitative Real-Time PCR and Digital PCR
For studies requiring mutation-load measurement, allele-specific hydrolysis probes in quantitative real-time PCR, or droplet digital PCR, quantify the mutant allele fraction with high precision. Droplet digital PCR in particular achieves sensitivity sufficient to detect very low-level mutant alleles, making it valuable for monitoring clonal dynamics after bone marrow transplantation or during drug treatment. These quantitative readouts complement standard genotyping and support pharmacodynamic endpoints in therapeutic studies.
Applications
JAK2 V617F genotyping underpins a wide range of preclinical and basic research activities involving mutant mouse strains:
- Breeding colony management, including confirmation of Mendelian allele transmission and early detection of genotype drift.
- Myeloproliferative neoplasm research covering polycythemia vera-like disease, essential thrombocythemia, and primary myelofibrosis.
- Evaluation of JAK inhibitors such as ruxolitinib, fedratinib, and pacritinib, as well as combination therapies.
- Hematopoietic stem cell biology and cytokine signaling studies exploring the JAK-STAT pathway.
- Thrombosis, inflammation, and cardiovascular comorbidity models associated with myeloproliferative disease.
- Bone marrow transplantation studies requiring verification of donor genotype and engraftment status.
FAQ
Why is molecular genotyping necessary if the disease phenotype is visible?
Phenotypic markers such as elevated hematocrit or splenomegaly are variable, age-dependent, and cannot distinguish heterozygous from homozygous animals. Molecular genotyping provides an unambiguous genotype call that is essential for correct breeding decisions, experimental grouping, and data interpretation.
Which sample type is recommended for routine testing?
Tail tip or ear punch biopsies are recommended for routine colony screening because they yield high-quality genomic DNA with minimal animal handling. Dried blood on FTA cards is an excellent alternative when samples must be shipped over long distances at ambient temperature.
How should samples be packaged and submitted?
Samples should be individually labeled with animal identification numbers and accompanied by a submission form listing strain, pedigree, and expected genotype. Tissue may be sent preserved in ethanol, dried, or frozen on dry ice, and blood should be collected in EDTA tubes to avoid PCR inhibition by heparin.
What is the typical turnaround time?
Standard PCR-based genotyping is generally completed within three to seven working days of sample receipt. Sanger sequencing confirmation and quantitative allele-burden assays may require several additional working days depending on sample volume and assay complexity.
How are genotyping results interpreted?
Reports specify the genotype call as wild-type, heterozygous, or homozygous mutant, together with the corresponding gel image, sequencing chromatogram, or quantitative allele fraction. An internal control band confirms successful DNA extraction and amplification, and ambiguous samples are retested at no additional charge.
Can homozygous Jak2 V617F mutants be used in experiments?
The utility of homozygous animals depends on the specific model. In many knock-in and conditional lines, homozygosity is associated with severe disease and reduced survival, so colonies are routinely maintained as heterozygotes. Researchers should consult the original model description and breeding guidelines before establishing experimental cohorts.